Opus Genetics, Inc.
IRD
$4.91
-$0.28-5.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 25.53% | 6.84% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 25.53% | 6.84% | |||
| Cost of Revenue | 62.71% | 6.43% | |||
| Gross Profit | -97.09% | -6.05% | |||
| SG&A Expenses | -1.83% | -13.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 34.49% | -3.38% | |||
| Operating Income | -37.81% | 6.68% | |||
| Income Before Tax | 5.33% | -135.23% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 5.33% | -135.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 5.33% | -135.23% | |||
| EBIT | -37.81% | 6.68% | |||
| EBITDA | -37.86% | 6.68% | |||
| EPS Basic | 17.04% | -111.02% | |||
| Normalized Basic EPS | 17.03% | -110.93% | |||
| EPS Diluted | 17.04% | -111.02% | |||
| Normalized Diluted EPS | 17.03% | -110.93% | |||
| Average Basic Shares Outstanding | 14.08% | 11.46% | |||
| Average Diluted Shares Outstanding | 14.08% | 11.46% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||